Skip to main content

Catherine Bowes Rickman

George and Geneva Boguslavsky Distinguished Professor of Eye Research
Ophthalmology, Vitreoretinal Diseases & Surgery
Box 3802 Med Ctr, Durham, NC 27710
5010 Albert Eye Research Institute, Durham, NC 27710

Selected Grants


Swept Source (SS-) OCT system for Ex-Vivo Imaging, and specialized human postmortem full tissue sample package preparation

ResearchPrincipal Investigator · Awarded by Janssen Research & Development, LLC · 2024 - 2028

Medical Scientist Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027

Training Program in Developmental and Stem Cell Biology

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2001 - 2027

Cell and Molecular Biology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institute of General Medical Sciences · 2021 - 2026

CFHR siRNAs in Cfh het mice

ResearchPrincipal Investigator · Awarded by Alnylam Pharmaceuticals · 2025 - 2025

Complement factor H modulates lipoprotein clearance in AMD

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2025

Genetic and Genomics Training Grant

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2020 - 2025

Preclinical Testing of Complement Factor H Gene Augmentation Therapy to Treat Dry AMD

ResearchPrincipal Investigator · Awarded by Foundation Fighting Blindness, Inc · 2022 - 2025

Stimulation of fatty acid oxidation to diminish drusen

ResearchPrincipal Investigator · Awarded by University of Washington · 2023 - 2024

RPE Exosomes in Age-related Macular Degeneration

FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2024

The Role of RPE-derived Exosomes in Deposit Formation and ECM Modulation

ResearchCollaborator · Awarded by National Institutes of Health · 2021 - 2022

RPE Trophic Activity for Retinal Protection

ResearchPrincipal Investigator · Awarded by University of Arizona · 2017 - 2022

HDL - a therapeutic target for age related macular degeneration.

ResearchPrincipal Investigator · Awarded by Edward N. & Della L. Thome Memorial Foundation · 2019 - 2021

Prevention of Early/Intermediate AMD using Anti-C5 Immunotherapy

ResearchPrincipal Investigator · Awarded by Research To Prevent Blindness, Inc. · 2018 - 2020

Dose range finding study for AAV8.CBA.humanFH vectors in CFH-deficient Mice

ResearchPrincipal Investigator · Awarded by Aevitas Therapeutics, Inc. · 2019 - 2020

Genetics Training Grant

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1979 - 2020

Testing the effect of a CFH agonistic monoclonal PEG-Fab

ResearchPrincipal Investigator · Awarded by Gemini Therapeutics · 2020 - 2020

Innate immunity, lipoproteins and AMD progression

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2019

Gemini Therapeutics, Inc.- SRA

ResearchPrincipal Investigator · Awarded by Gemini Therapeutics · 2018 - 2018

The Role of Exosomes in Dry AMD

ResearchCollaborator · Awarded by BrightFocus Foundation · 2015 - 2018

Regulation of Sub-RPE Deposit Formation in AMD by Local and Systemic Complement Factor H

ResearchPrincipal Investigator · Awarded by Foundation Fighting Blindness, Inc · 2015 - 2018

Targeting Amyloid beta for the treatment of dry Age-related Macular Degeneration

ResearchPrincipal Investigator · Awarded by F. Hoffmann-La Roche Ltd · 2015 - 2015

Ocular Pharmacology and Therapeutics Conference

ConferenceMember, Planning Committee · Awarded by National Institutes of Health · 2014 - 2015

Complement and Pathogenic Mechanisms of AMD

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2015

A non-canonical role for b-secretase in AMD

ResearchPrincipal Investigator · Awarded by The Trustees of Indiana University · 2013 - 2014

Candidate Genes for Primary Open Angle Glaucoma

ResearchConsultant · Awarded by National Institutes of Health · 2007 - 2012

The Molecular Basis of Pseudoexfoliation Syndrome

ResearchMentor · Awarded by National Institutes of Health · 2003 - 2009

Proteome Map of the Photoreceptor Cell

ResearchConsultant · Awarded by National Institutes of Health · 2006 - 2009

Murine AMD Model Based on Constellation of Known Human AMD Risk Factors

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2006 - 2008

Characterization of Genes in Normal and AMD Retinas

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 2006

Characterization of Genes in Normal and AMD Retinas

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 2001

External Relationships


  • 4D Molecular Therapeutics
  • Aerie Pharmaceuticals, Inc.
  • Alnylam Pharmaceutical, Inc.
  • Character Biosciences
  • Cognition Therapeutics, Inc.
  • Foundation Fighting Blindness, Columbia, MD
  • Perfuse Therapeutics
  • Retinal degeneration (RD) Fund
  • Sanofi

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.